Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chenzhou Mingrun Biological Products is a specialized biotechnology company focused on the production of heparin-based active pharmaceutical ingredients (APIs). Headquartered in Chenzhou, Hunan Province, China, the company excels in the extraction and purification of heparin sodium and crude heparin from porcine intestinal mucosa. It serves as a critical supplier to the global pharmaceutical market, providing high-quality raw materials for anticoagulant medications. The company's manufacturing processes are designed to comply with international quality standards for biological products. Its portfolio supports the treatment of various thromboembolic conditions, including deep vein thrombosis and pulmonary embolism. Chenzhou Mingrun Biological Products plays a significant role in the upstream supply chain for cardiovascular health solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chenzhou Mingrun Biological Products.